Bart A Jessen

2PUBLICATIONS
0CO-AUTHORS
Radiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Sep 29, 2023
Correction to: An IQ consortium analysis of starting dose selection for oncology small molecule first‑in‑patient trials suggests an alternative NOAEL‑based method can be safe while reducing time to the recommended phase 2 dose.

Bart A Jessen, Paul Cornwell, Sean Redmond

|Jul 28, 2023
An IQ consortium analysis of starting dose selection for oncology small molecule first-in-patient trials suggests an alternative NOAEL-based method can be safe while reducing time to the recommended phase 2 dose.

Bart A Jessen, Paul Cornwell, Sean Redmond

Pageof 1

Frequent Collaborators